| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other income (expense), net | 64,908 | 19,472 | ||
| Net loss | -5,407,470 | -5,949,405 | ||
| Net loss per share attributable to common stockholders, basic | -0.25 | -0.3 | ||
| Net loss per share attributable to common stockholders, diluted | -0.25 | -0.3 | ||
| Weighted-average shares of common stock outstanding, basic | 21,394,965 | 19,646,475 | ||
| Weighted-average shares of common stock outstanding, diluted | 21,394,965 | 19,646,475 | ||
ACTUATE THERAPEUTICS, INC. (ACTU)
ACTUATE THERAPEUTICS, INC. (ACTU)